Inspection Record

Biologics Manufacturing Centre (BMC) Inc. — Health Canada Inspection Findings

Health CanadaInspected 2024-05-13 11 findingsContamination controlEquipment and facilityMaterial and supplier controlAseptic processing and sterility assuranceDeviation, CAPA, and investigationStability and storageOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Contamination control

The premises were not designed, constructed, operated, and/or maintained to prevent contamination.

2Equipment and facility

The design, location, and/or maintenance of the equipment was inadequate for allowing the equipment to serve its intended purpose

3Equipment and facility

Evaluation of production processes, equipment, and/or materials was inadequate.

4Material and supplier control

The handling and/or storage of samples was inadequate for raw materials, drugs being processed, bulk drugs, and/or finished products.

5Material and supplier control

The specifications for any packaging materials were incomplete or inadequate.

6Aseptic processing and sterility assurance

The validation of aseptic processing was inadequate.

7Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

8Stability and storage

The temperature and/or humidity control was inadequate.

9Other quality system

The recorded information or details were inadequate.

10Aseptic processing and sterility assurance

Evaluation of production processes, equipment, and/or materials was inadequate. Sterile disinfectants were not used in Grade A and B areas. The company did not monitor the aseptic filling area frequently enough to avoid possible contamination or system deterioration. The company did not adequately demonstrate that air-flow patterns did not pose a risk of contamination.

11Material and supplier control

The protection of products and/or materials from contamination was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2024-05-13. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Biologics Manufacturing Centre (BMC) Inc. company profile — full history Health Canada documents, 2024 Go to Findings search